Skip to main content
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Keyword
Specialties
Allergy & Immunology
Autoimmune
CardioVascular
Clinical Pathways
Dentistry
Dermatology
Emergency & Mobile Medicine
Endocrinology & Diabetes
Gastroenterology
Infectious Diseases
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Pediatrics
Podiatry
Population Health
Psychiatry & Behavioral Health
Pulmonology
Rheumatology & Arthritis
Surgery
Urology
Wound Care
Events
Education
About
Sign In
Search
Sven de Vos, MD, PhD
What is New in the Approach to DLBCL Upfront and in the Relapsed Setting?
Sven de Vos , MD, PhD;
03/10/2020
ZUMA-12: A Phase 2 Multicenter Study of Axicabtagene Ciloleucel as a First-Line Therapy in Patients With High-Risk Large B Cell Lymphoma
Purpose of the Study: Patients with large B cell lymphoma (LBCL) who have persistent disease assessed by dynamic positron emission tomography after rituximab-based induction therapy have ...
Jun Kawashima ;
Alex F. Herrera ;
Sven de Vos , MD, PhD;
Sattva S. Neelapu ;
Julio C. Chavez ;
Yi Lin ;
Javier Munoz ;
Lovely Goyal ;
Chaitra S. Ujjani ;
Peter Riedell ;
Olalekan O. Oluwole ;
Natasha Kekre ;
Kate Backhouse ;
Francesca Milletti ;
10/22/2019
Subcutaneous Epcoritamab Combined With Rituximab + Lenalidomide for the Treatment of Patients with Relapsed or Refractory Follicular Lymphoma: Phase 1/2 Trial Update
Introduction:
Jacob H. Christensen ;
Sven de Vos , MD, PhD;
Harald Holte ;
Kim M. Linton ;
Aqeel Abbas ;
Minh Dinh ;
Brian Elliott ;
David Belada ;
Sirpa Leppä, ;
Lorenzo Falchi ;
Bjorn E. Wahlin ;
Marcel Nijland ;
11/04/2022
Featured Webinar
Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications
Upcoming Events
February 2 – February 5
February 27 – March 1
March 17 – March 19
March 27 – March 30
March 31 – April 2
April 21 – April 24
April 30 – May 4
April 30 – May 5
May 1 – May 3
May 19 – May 21
See Full Calendar